ENTITY
Ascletis Pharma

Ascletis Pharma (1672 HK)

112
Analysis
Health Care • China
Ascletis Pharma is a fully integrated biotechnology company focused on the research, development, production, marketing, and sale of innovative pharmaceutical products. The company's marketed products include Ritonavir tablets, GANOVO®, and ASCLEVIR® for Hepatitis C, and it has a robust pipeline primarily in metabolic diseases, viral diseases, and oncology. Ascletis Pharma is headquartered in Hangzhou, China, and was founded in 2011.
more
Company Event • 30 Mar 2027 16:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 31 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 10 Aug 2026 16:00 • Upcoming
Add To Calendar

Corporate presentation

Company Event • 31 Mar 2026 16:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 15 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

x